BIONET Therapeutics Corp. (TPEX:7808)
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.07 billion as of November 20, 2026. It is the 27,843rd most valuable company in the world and the 1,510th biggest in Taiwan. Its market cap has decreased by 47.14% in one year.
Market Cap
2.07B
Enterprise Value
1.08B
Revenue
211.96M
Global Rank
Country Rank
#1,510 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.07B, a decrease of -45.69%. That is a compound annual growth rate of -27.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.07B | -47.33% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elixiron Immunotherapeutics (Cayman) Limited | 15.24B |
| HanchorBio | 15.12B |
| Intelligene | 7.34B |
| Obigen Pharma | 7.29B |
| Uwell Biopharma | 5.13B |
| Tripartite Therapeutics | 3.86B |
| Pet Pharm Biotech | 2.71B |
| Genomics BioSci & Tech. | 1.07B |